Virtu KCG Holdings’s GSK GSK Stock Holding History

Virtu KCG Holdings’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-12,800	Closed	-$646K	–	3158
2015 Q4	$646K	Sell	12,800 -6,400	-33%	-$326K	0.01%	1262
2015 Q3	$923K	Buy	19,200 +3,680	+24%	+$192K	0.02%	955
2015 Q2	$808K	Sell	15,520 -5,440	-26%	-$306K	0.01%	1051
2015 Q1	$1.21M	Sell	20,960 -4,720	-18%	-$271K	0.02%	640
2014 Q4	$1.37M	Sell	25,680 -1,440	-5%	-$80.6K	0.02%	671
2014 Q3	$1.56M	Buy	27,120 +10,400	+62%	+$638K	0.03%	632
2014 Q2	$1.12M	Sell	16,720 -13,760	-45%	-$931K	0.02%	1065
2014 Q1	$2.04M	Sell	30,480 -13,680	-31%	-$925K	0.03%	668
2013 Q4	$2.95M	Buy	44,160 +20,480	+86%	+$1.33M	0.03%	430
2013 Q3	$1.49M	Buy	+23,680	New	+$1.52M	0.02%	836

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Virtu KCG Holdings's GSK Position: Q2 2017 in Review

Virtu KCG Holdings reduced its GSK (GSK) stake by 63% in Q2 2017, selling an estimated $1.55M and leaving 17,054 shares worth $919K. The position accounts for 0.03% of the portfolio, ranked #631.

Virtu KCG Holdings first reported a position in GSK in Q3 2013 and has held it in 15 quarters since. The position peaked at $17.7M in Q3 2013. 779 funds tracked by Wall St. Rank hold GSK as of Q2 2017.

Virtu KCG Holdings held 17,054 shares of GSK worth $919K as of Q2 2017.
Virtu KCG Holdings sold 29,060 GSK shares in Q2 2017, an estimated $1.55M.
GSK made up 0.03% of Virtu KCG Holdings's portfolio in Q2 2017, its #631 holding.
Virtu KCG Holdings first reported a position in GSK in Q3 2013 and has held it in 15 quarters since.
Virtu KCG Holdings's GSK position peaked at $17.7M in Q3 2013.
779 funds tracked by Wall St. Rank held GSK as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.